Cerus reported $-1.45M in Operating Profit for its fiscal quarter ending in December of 2024.





Operating Profit Change Date
Cerus USD -1.45M 488K Dec/2024
GRIFOLS EUR 394M 65M Sep/2026
Haemonetics USD 75.12M 17.66M Sep/2026
Neogen USD -1.8M 4.9M Jun/2026
OraSure Technologies USD -13.59M 2.13M Dec/2025
Plus Therapeutics USD -7.12M 1.38M Mar/2026
Quidel USD 12.1M 27.4M Sep/2026
Rockwell Medical USD 515K 1.84M Jun/2024
STAAR Surgical USD 5.46M 4.64M Sep/2026
Terumo JPY -18.68B 108.16B Sep/2026
Utah Medical Products USD 2.56M 124K Mar/2026